Monday, July 25, 2011

London's AIM - Spectra Systems Raises $23 Million in London AIM IPO

With 2010 revenue of $7.3m and net income of $0.4m, the Company was able to command an opening valuation on the London Stock Exchange's AIM of $55.5m.  Future growth opportunities are focused on the United Kingdom, India and China.

CEO Nabil Lawandy is quoted as saying, “We are delighted that the listing on London's AIM of the Company has been completed successfully and with such high levels of institutional demand.  This listing on London's AIM makes both strategic and commercial sense for the Company as we take Spectra Systems to the next stage of its development and we look forward to working closely with our new London AIM institutional shareholders as the Company executes its plans for growth.  London's AIM is located at the center of the world’s economy.  Spectra’s growth and increased shareholder value are based on the continued adoption of our products by central banks regulating the economies of key G20 countries.  London's AIM is positioned to give us the visibility to accelerate this process.”

The Nominated Adviser and Nominated Broker commented, “There has been exceptional demand for the Spectra Systems’ London Stock Exchange AIM IPO, and we are particularly pleased to have such strong institutional investors on board going forward.  The Spectra Systems' story is a strong one, and this successful London Stock Exchange AIM IPO validates the fact that there is appetite from blue chip investors for small and mid-cap companies listing on London's AIM that have compelling growth prospects.”

Overview of IPO Listing on London's AIM
Providence, Rhode Island-based Spectra Systems' London AIM IPO raised $23 million in its recent IPO on the London Stock Exchange’s Alternative Investment Market (AIM).

Spectra Systems’ invents, develops, manufactures and markets advanced, technology-based products used to mark, track and authenticate high value goods.  The Company’s security materials include proprietary and patented consumables and hardware and software systems which authenticate bank notes, documents, passports and products such as pharmaceuticals, software, optical disks and branded luxury goods.  The Company’s consumables, hardware and software often work together as a public and/or covert ‘lock-and-key’ system in the authentication process.

Spectra Systems was founded in 1996 to commercialize technology licensed from Brown University.  The Company’s corporate office is in Providence, Rhode Island and its laboratory facilities are across the river in East Providence.  Spectra Systems has 20 employees; 11 in engineering, service and application support, four in research and development, three in finance, management and administration and two in sales and marketing.  Future growth opportunities are focused on the United Kingdom, India and China.

London AIM Key Listing Metrics
  • $22.8m gross was raised upon listing on the London Stock Exchange's AIM, $20.8m net of offering costs, intended to be used for: 
    • $2.0m - Marketing a new generation security feature to the central banks of India and China
    • $1.5m - Plant and equipment to manufacture consumable materials in-house 
    • $1.0m - Completion of the development of banknote fitness sensing technology 
    • An unspecified amount for strategic acquisitions 
    • An unspecified balance for general working capital
  • Offering costs on the London Stock Exchange's AIM amounted to 8.6% of the gross capital raised
    • Undertaken on a ‘best efforts’ basis, as opposed to being underwritten 
      • Nominated Broker commission of 5.0% 
      • Plus three-year warrants over 1.0% of the enlarged share capital at the London AIM IPO price
    • Corporate finance fee of £125k ($204k)
  • Opening market capitalization upon listing on London's AIM of $55.5m
  • Dilution to existing shareholders of 41.1%
  • Free float on London's AIM of 81%
  • Trailing pre-money and post-money revenue multiples on the London Stock Exchange's AIM of 4.5 and 7.6, respectively
  • Trailing pre-money P/E ratio on London's AIM of 81.8[1]
  • Trailing pre-money EBITDA and Adjusted EBITDA multiples on London's AIM of 54.5 and 40.1, respectively1

Key Financial Metrics

(in USD millions)
Y/E 12/31/08
Y/E 12/31/09
Y/E 12/31/10
Δ from 2008
Δ from 2009






Revenue
$7.0
$7.4
$7.3
  +4%
   -1%
Cost of Goods Sold
 2.8
 3.5
 2.9
  +4%
 -17%
Operating Expenses
 3.5
 3.6
 4.0
+14%
+11%
Income Before Tax
 0.7
 0.3
 0.4
 -43%
+33%
EBITDA
 0.9
 0.4
 0.6
 -33%
+50%
Adjusted EBITDA[2]
 1.2
 0.8
 0.8
 -33%
    0%
Accumulated Deficit
31.4
29.8
29.5
 N/A
 N/A
Cash and Cash Equivalents
 2.4
 3.4
 3.4
 N/A
 N/A

The Company’s revenues are highly concentrated with a very small number of governmental entities; with 95%, 94% and 82% of 2008, 2009 and 2010 revenues, respectively, earned from three, three and two customers, however, these types of customers pose very low non-collection risk.  Since the London AIM IPO completed within nine months of the latest audited financial statements, unaudited, comparative stub period financials were not required and the Company chose not provided updated management accounts.

Shareholder Base
The Company had 9.5m common shares outstanding prior to the London Stock Exchange AIM IPO, 17.2m common shares were issued in connection with the London AIM IPO via the conversion of preferred shares and 18.6m common shares were issued for cash in the London AIM IPO, leaving the Company with 45.3m common shares outstanding.  The table below details those who owned 3% or more of the Company prior to and after the London Stock Exchange AIM IPO, taking retrospective account of the preferred share conversions, along with the collective ownership of the Other Historic Investors, the Directors and the Other New London Investors.

Shareholder
  Pre-IPO %
  Post-IPO %



U.S. Strategic Investor (Papermaking Technology), NYSE-listed
 11.86
     6.98[3]
Asian/U.S. Special Situations’ Investor
   6.80
   4.01
Panamanian-domiciled Investment Fund
   4.13
   2.43
U.S. Strategic Investor (Banknote and Passport Paper Manufacturing)
   4.01
   2.36
U.S. Strategic Investor (Book Printing and Publishing)
   3.92
   2.31
Isle of Man-domiciled Company
   3.73
   2.20
Other Historic Investors
 44.44
 26.18
Directors
 21.11
  12.46[4]
London Institutional Investor (Fund Manager)
       -
   9.83
London Institutional Investor (Fund Manager)
       -
   7.34
London Institutional Investor (Fund Manager)
       -
   5.87
London Institutional Investor (Insurance)
       -
   5.87
London Private Client Broker
       -
   3.86
Other New London Investors
       -
   8.30
     Totals
100.00
100.00

The Company was backed by several Strategic Investors, several Financial Investors and a range of Other Historic Investors.  All of the pre-IPO investors retained their shareholdings and were simply diluted as a result of the new shares issued in the London Stock Exchange AIM IPO.  The London Institutional Investors, the London Private Client Broker and the Other New London Investors took up the entire London AIM IPO.

Beyond the obvious benefit of raising capital from listing on London's AIM for organic and acquisitive growth, the Company now has a more diversified shareholder base from which to create post-IPO liquidity on London's AIM and new London-based AIM investors to diversify the risk of any future financings on London's AIM.  As a public company listed on the London Stock Exchange's AIM, Spectra Systems’ corporate standing and profile will be raised, particularly in the United Kingdom, its share option plan will be more attractive to existing and prospective employees and Board members and its common shares listed on London's AIM will be more attractive to potential acquisition targets.

London AIM Board of Directors and Corporate Governance
The Board of Directors consists of one Executive Director (the Founder, President and CEO) and six Non-Executive Directors, all with solid resumes and a good blend of complementary experiences and skill sets.  Given the sensitivity of the Company’s technologies and products, one unique requirement is that the Board be comprised of a majority of U.S. citizens, as mandated by the U.S. Department of Security Services, the regulatory body of suppliers to the U.S. Government.  As such, four of the seven Directors are U.S. citizens.

Companies listed on the London Stock Exchange's AIM are not required to comply with the U.K. Corporate Governance Code, which is mandatory for companies listed on the Main Market of the London Stock Exchange (LSE); however, the Company intends to comply with the Corporate Governance Guidelines for Smaller Quoted Companies which are published by the Quoted Companies Alliance.  The Board intends to meet at least six times per year and as deemed necessary.

The Company has established an Audit Committee, a Compensation Committee and a Government Security Committee.  Each committee consists of between two and four members with the Executive Director only being represented on the Government Security Committee.

London AIM Accounting Considerations
Since the Company remained incorporated under the laws of the State of Delaware and did not re-domicile into a European Economic Area country, which includes the U.K., they chose to report using U.S. GAAP.  While, not required, a summary of the relevant differences between U.S. GAAP and IFRS was provided.

The U.K. Member Firm of an international accountancy network acted as Reporting Accountant while the U.S. Member Firm of another international accountancy network audited the 2008 - 2010 financials.  Since the 2010 financials were less than nine months old, unaudited, comparative stub periods were not required.

An unaudited pro forma statement of net assets is never required in connection with a London AIM IPO and was not provided in this instance since the Company does not have any debt; therefore, the effect of the net proceeds from the London Stock Exchange AIM IPO on the net assets of the Company is obvious.

London AIM Legal Considerations
While the Company remained incorporated under the laws of the State of Delaware, its constitutional documents were amended to incorporate the most important elements of English corporate law as follows:
  1. Pre-emption Rights (i.e. anti-dilution) – Shareholders may participate in, or the Company has to obtain approval from at least 75% of them for, the issuance of shares on London's AIM for cash of more than 10% of the then outstanding shares listed on London's AIM during any 12-month period.  These pre-emption rights will cease to apply if the Company becomes a reporting company under the U.S. Exchange Act, the most common reason being a dual listing on a U.S. securities exchange such as NASDAQ.
  2. Notifiable Interests – Shareholders are required to notify the Company of, and the Company is required to publicly announce, holdings at or above the 3% level and whenever a full percentage point is breached in either direction.
  3. Takeovers (i.e. mandatory offer) – If any party, or parties acting in concert, accumulates a holding of 30% or more, they must make a cash offer to the other London AIM shareholders at the highest price they paid for the Company’s shares listed on London's AIM during the last 12 months.
The Company relied on the safe harbor afforded by Regulation S of the U.S. Securities Act of 1933 so as to not have to file a registration statement with the U.S. SEC.  Shares subject to Reg. S (generally, those issued in the London Stock Exchange AIM IPO, issued one year before the London AIM IPO and/or held by affiliates) are not eligible for dematerialization and, as such, are always held and traded in certificated form.

Since the Company did not re-domicile into the U.K. or one of its Crown Dependencies, the Channel Islands and Isle of Man, its London Stock Exchange AIM-listed shares that are not subject to Reg. S are not eligible for trading within CREST; the most common electronic system for the holding and transfer of shares listed on London's in the U.K., however, a Depository could be appointed and Depository Interests (DIs) could be created which would be eligible for trading within CREST.

Due to the sensitivity of the Company’s technologies and products, they chose to not create DIs for their London AIM-listed shares that are not subject to Reg. S so as to mitigate the risk of non-compliance with certain U.S. federal laws and trading and economic sanctions enforced by the U.S. Office of Foreign Assets Control and the U.S. Department of Defense regarding ‘unauthorized parties’ holding shares in the Company and ‘non-U.S. persons’ holding a stake of 5% or more given the potential for access to classified information and the potential for exercising control over, or influencing, the business or management of the Company.

The London Stock Exchange AIM-listed Company has two share trading lines, Reg. S and Unrestricted, and both represent securities with identical rights.

Other
Given the nature of the Company’s business, advanced, technology-based products used to mark, track and authenticate high value goods; Experts’ Reports on the technology and intellectual property were prepared, however, they were kept confidential given the sensitivity of the Company’s technologies and products.

[1] Not particularly meaningful given the relatively small denominators.
[2] Only adds back stock-based compensation expense.
[3] Subject to a six-month lock-in on the London Stock Exchange's AIM.
[4] Subject to a 12-month lock-in on London's AIM and customary orderly market provisions on London's AIM for a further 12 months.

Wednesday, June 8, 2011

The New York Times - Fleeing to Foreign Shores - Fast Growing U.S. Companies Look Abroad for Investors

I am pleased to share some coverage of the London Stock Exchange's AIM in The New York Times.  The article discusses the decade-long trend of American companies completing IPOs overseas and cites AIM as a popular destination.

Graham Bowley, Reporter, The New York Times, New York, New York, U.S.A.

Reva Medical, a maker of medical devices in San Diego, wanted to go public last year to raise money to satisfy impatient venture capitalists and finance research for its heart stents.

But it found little investor interest in the United States for an early-stage medical device company that had not yet made a profit.

Reva Medical did what a small but increasing number of young American companies are doing — it looked abroad for money, in Reva’s case the Australian Stock Exchange.

After an eight-month road show, meeting investors and pitching the prospects of a biodegradable stent, the 12-year-old company sold 25% of its stock for $85 million in an initial public offering in December.

“There are so many companies that require capital like our company, and they don’t have access to the capital markets in the United States,” said Robert Stockman, Reva’s chief executive.  “People are looking at any option to stay alive, which is what we did.”

Reva’s example shows that nearly three years since the financial crisis began, markets in the United States are barely open to many companies, leading them to turn to investors abroad.  Denied a chance to list their stock and go public here, they are finding ready buyers of their shares on foreign markets.

Nearly one in 10 American companies that went public last year did so outside the United States.  Besides Australia, they turned to stock markets in Britain, Taiwan, South Korea and Canada, according to data from the consulting firm Grant Thornton and Dealogic.

The 10 companies that went public abroad in 2010 — and 75 from 2000 to 2009 — compares with only two United States companies choosing foreign exchanges from 1991 to 1999.

The trend reflects a decidedly global outlook toward stocks, just as the number of public companies in the United States is shrinking.

From a peak of more than 8,800 American companies at the end of 1997, that number fell to about 5,100 by the end of 2009, a 40% decline, according to the World Federation of Exchanges.

The drop comes as some companies have merged, or gone out of business, or been taken private by private equity firms.  Other young businesses have chosen to sell themselves to bigger companies rather than go public.

To be sure, as the economy improves and investors shaken badly by the financial crisis begin to regain their confidence, American stock markets may once again open up for companies trying to go public and listings may rise in the United States.

LinkedIn, the social networking site for business professionals, had a successful initial public offering last month on the New York Stock Exchange, and Groupon, the social buying site, has registered its plans to go public in the United States.

But these are big companies, enjoying the popularity of being Internet darlings.  Executives and analysts fear that a long-term structural shift in American equity markets means these markets are now closed to legions of smaller, more ordinary businesses.  They could more easily have gone public in the United States in the past.  But they now remain private or, for the time being, have to market themselves overseas and rely on foreign investors.

For example, initial public offerings by American companies totaled only 119 in the United States last year, according to Dealogic — higher than the depressed rates of the previous two years but a far cry from the 756 companies that went public at the peak in 1996.

As young, fast-growing companies are forced to look overseas for public status and investors, executives and analysts fear that they may increasingly shift their geographic focus — and as a result any jobs they create will be abroad.

“Issuers have to put themselves through a grinder to go overseas, so any significant percentage of overseas listings is a sign that our markets have become hostile to innovation and job formation,” said David Weild, a former vice chairman of the NASDAQ stock exchange and a senior adviser to Grant Thornton.

A variety of factors explain each company’s decision to list on a foreign exchange, like the increased regulatory costs of going public in the United States.  Underwriting, legal and other costs are typically lower in foreign markets, companies say.

The Alternative Investment Market, or AIM, a part of the London Stock Exchange intended for small company listings, is a popular destination for some American companies.  The cost of an initial public offering on the London Stock Exchange's AIM is about 10 – 12% of total capital raised, compared with 13 – 15% on NASDAQ, according to Mark McGowan of AIM Advisers, which helps U.S. companies list on London's AIM.

In addition, the extra annual cost of maintaining a public listing, including complying with Sarbanes-Oxley rules, can be typically much higher in the United States: $2 million to $3 million each year depending on the size of a company compared with a cost as low as $320,000 on London's AIM or $100,000 to $300,000 in a market like Taiwan, according to advisers.

There are concerns that some foreign exchanges attract companies because their oversight may be less stringent.  But companies insist standards are high.

A more important factor than cost, said Sanjay Subhedar, managing director of Storm Ventures, a California venture capital firm, is that investors in the United States who traditionally participate in I.P.O.’s and the banks that underwrite the offerings are no longer interested in share sales by small companies.

Institutional investors like mutual funds want the liquidity of larger offerings with abundant buyers and sellers, he said; bank underwriters want to focus on the more lucrative fees that bigger deals generate.

One of the companies he invests in, Integrated Memory Logic (IML), of Campbell, Calif., last year became one of the first non-Taiwanese companies to list on the Taiwan Stock Exchange.  A supplier of semiconductor chips for LCD screens, it raised $40 million with a 10% sale of the company after the exchange changed its rules to allow foreign companies to join.

Integrated Memory Logic, which had a work force of 60 when it went public, has since added a handful of engineers in the United States but also another 40 employees in Shanghai, Taipei and Seoul, South Korea.

“Because of the nature of the industry, large mutual fund companies and investment banks don’t want to do an offering of less than $100 million,” said Mr. Subhedar.  “This means unless the company has a market size of $500 million, you can’t really go public in the United States.  We were in the $250 million to $350 million range.”

Another reason to go abroad, some American businesses like HaloSource of Seattle are discovering, is that investors in the United States may not be as interested as foreign investors in companies whose growth potential is strongest overseas.

HaloSource makes water purification devices for use in American pools and spas but also for drinking water in countries like India, China and Brazil.  Last year, it had an $80 million IPO on London's AIM.  One reason it chose London AIM, according to James Thompson, chief financial officer, was that London AIM investors were more sympathetic to growth opportunities in emerging markets.  ”Though London's AIM is a smaller capital market than New York, London's AIM is much more globally focused.”

For some London AIM-listed companies like HaloSource, the move to a foreign exchange may make longer term strategic sense as their growth shifts away from America to markets like China and India.  Integrated Memory Logic’s biggest suppliers of the wafers for its semiconductor chips and its biggest customers are in Asia — so a listing in Taiwan raises its profile in a region that is already home to most of its corporate partners.

Another company, Samsonite, the luggage company that was founded in Denver in 1910 but shifted its corporate location to Luxembourg in 2009, now sees most of its growth coming from Asia.  It plans a $1.5 billion offering in Hong Kong next week.

The attraction of an Asian listing will be underlined further this month when Prada, the Italian fashion house, lists its shares in an offering that could generate $2.5 billion, also in Hong Kong.

But while some companies see their foreign I.P.O. as a long-term move, others see it as an interim step, one that after further expansion could lead them to seek investor interest back home and a dual listing in the United States.

One reason Reva Medical chose Australia was that country’s system of research hospitals that it intends to use for its clinical trials.

Mr. Stockman, the chief executive, also sits on the board of another company, HeartWare International, based in Massachusetts and Florida, that carried out an Australian I.P.O. in 2005, and then listed on NASDAQ in the United States in 2008.

In its Australian I.P.O., Reva sold stock to investors from Britain, Australia and Hong Kong, as well as America.

Mr. Stockman said two Wall Street investment banks told him there was no interest in an offering of the company in the United States.  Instead, he found an underwriter, Inteq, in Australia.  In the end, the cost of the Australian listing was $7 million, roughly what it would have cost Reva to list in the United States, he said.

One of the biggest costs was travel time and flights.  He concedes that he would have preferred to list in the United States in the first place — after all the traveling back and forth to Australia, and the long road show in Asia, the United States and Europe.

“All things being equal, it would have been easier,” he said. “It is a long way.”